Cargando…

A Slower Age-Related Decline in Treatment Outcomes After the First Ovarian Stimulation for in vitro Fertilization in Women With Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS) patients have a better ovarian reserve and age-related improvement in endocrine disturbances than non-PCOS patients. The effects of age on in vitro fertilization (IVF) treatment outcomes associated with cumulative live birth rate (CLBR) remain unclear. Ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Liu, Xiaocong, Hu, Linli, Zhang, Fuli, Wang, Fang, Kong, Huijuan, Dai, Shanjun, Guo, Yihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906164/ https://www.ncbi.nlm.nih.gov/pubmed/31866942 http://dx.doi.org/10.3389/fendo.2019.00834

Ejemplares similares

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis
por: Yang, Liu, et al.
Publicado: (2023)

Predictive Factors for Live Birth in Fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment in Poor Ovarian Reserve Patients Classified by the POSEIDON Criteria
por: Li, Fei, et al.
Publicado: (2021)

The Combined Impact of Female and Male Body Mass Index on Cumulative Pregnancy Outcomes After the First Ovarian Stimulation
por: Zhao, Zhonghua, et al.
Publicado: (2021)

The Development of Nomograms to Predict Blastulation Rate Following Cycles of In Vitro Fertilization in Patients With Tubal Factor Infertility, Polycystic Ovary Syndrome, or Endometriosis
por: Jin, Haixia, et al.
Publicado: (2021)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

The Effect of Sperm DNA Fragmentation on In Vitro Fertilization Outcomes for Women With Polycystic Ovary Syndrome
por: Wang, Huan, et al.
Publicado: (2022)

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome
por: Yang, Fang, et al.
Publicado: (2023)

Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
por: Liu, Su, et al.
Publicado: (2020)

ANGPTL4 Expression in Ovarian Granulosa Cells Is Associated With Polycystic Ovary Syndrome
por: Jiang, Qi, et al.
Publicado: (2022)

Development of an acute ovine model of polycystic ovaries to assess the effect of ovarian denervation
por: Duncan, W. Colin, et al.
Publicado: (2023)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome
por: Shah, Mohd Zahoor Ul Haq, et al.
Publicado: (2023)

Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation
por: Jiang, Xue, et al.
Publicado: (2022)

Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After In-Vitro Fertilization/Intracytoplasmic Sperm Injection
por: Wang, Qiumin, et al.
Publicado: (2022)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Editorial: Epigenetics of polycystic ovary syndrome
por: Parker, Jim, et al.
Publicado: (2023)

Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
por: Huang-Doran, Isabel, et al.
Publicado: (2016)

Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome
por: Li, Fei, et al.
Publicado: (2021)

Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
por: Tian, Ye, et al.
Publicado: (2023)

The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study
por: Chen, Hanxiao, et al.
Publicado: (2021)

The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study
por: Zhang, Menghui, et al.
Publicado: (2023)

Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
por: Li, Youran, et al.
Publicado: (2022)

Effects of intestinal flora on polycystic ovary syndrome
por: Liu, Jiayue, et al.
Publicado: (2023)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

Ovarian Reserve and Serum Concentration of Thyroid Peroxidase Antibodies in Euthyroid Women With Different Polycystic Ovary Syndrome Phenotypes
por: Adamska, Agnieszka, et al.
Publicado: (2020)

Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome
por: Song, Linyi, et al.
Publicado: (2022)

The Association Between Genetically Predicted Systemic Inflammatory Regulators and Polycystic Ovary Syndrome: A Mendelian Randomization Study
por: Chen, Hanxiao, et al.
Publicado: (2021)

Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: A pilot study
por: Ding, Ying, et al.
Publicado: (2022)

Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis
por: Beitl, Klara, et al.
Publicado: (2022)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

High Thyroid Stimulating Hormone Level Is Associated With Hyperandrogenism in Euthyroid Polycystic Ovary Syndrome (PCOS) Women, Independent of Age, BMI, and Thyroid Autoimmunity: A Cross-Sectional Analysis
por: Cai, Jie, et al.
Publicado: (2019)

Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management
por: Wang, Yishu, et al.
Publicado: (2022)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Unkeito promotes follicle development by restoring reduced follicle-stimulating hormone responsiveness in rats with polycystic ovary syndrome
por: Yoshita, Sayako, et al.
Publicado: (2023)

Effect and Relationship of Seasons on the High Risk of Ovarian Hyperstimulation Syndrome After Oocyte Retrieval in Patients With Polycystic Ovary Syndrome
por: Cao, Yurong, et al.
Publicado: (2021)

A Genetically Defined Male Counterpart of Polycystic Ovary Syndrome: Evidence for Ovarian-Independent Pathogenesis
por: Zhu, Jia, et al.
Publicado: (2021)

Personality and Psychiatric Disorders in Women Affected by Polycystic Ovary Syndrome
por: Scaruffi, Elisabetta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u4159s0slrv7l92qqopo1r2qi4